|3Dec 19, 6:05 AM ET

Cystic Fibrosis Foundation 3

3 · Aridis Pharmaceuticals, Inc. · Filed Dec 19, 2022

Insider Transaction Report

Form 3
Period: 2022-12-08
Holdings
  • Common Stock, par value $0.0001 per share

    5,168,732

Documents

1 file
  • 3
    doc3.xmlPrimary

    FORM 3 SUBMISSION